Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The goal of this prospective study is to learn about the operative outcomes in patients with pituitary adenoma who receive endoscopic resection.
The main question it aims to answer is:
• What are the outcomes of patient following endoscopic resection? including visual, hormonal, survival, and functional outcomes.
Participants' data including clinical history, laboratory data, radiographic images, intraoperative videos will be evaluated and analyzed.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Endoscopic endonasal surgery | Other | Patients who received endoscopic endonasal resection of pituitary adenomas |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Endoscopic endonasal surgery | Procedure | Endoscopic endonasal transsphenoidal approach for resection of pituitary adenomas |
|
| Measure | Description | Time Frame |
|---|---|---|
| Visual field | The postoperative visual field will be assessed with standard visual perimetry and compared with preoperative measurements. | 6 months |
| Diabetes insipidus | Postoperatively, the patient's urine output and urine specific gravity will be measured to determine if the patient had diabetes insipidus. If the patient had diabetes insipidus, the duration of the diabetes insipidus will be recorded. | 6 months |
| Cortisol level | Postoperative serum cortisol level will be measured and compared to preoperative levels. | 6 months |
| Thyroid hormone level | Postoperative serum TSH and free T4 level will be measured and compared to preoperative levels. | 6 months |
| Prolactin level | Postoperative serum prolactin level will be measured and compared to preoperative levels. | 6 months |
| IGF-1 level | Postoperative serum IGF-1 level will be measured and compared to preoperative levels. | 6 months |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Jung-Shun Lee, MD | Contact | +886-6-2353535 | 5291 | nslee1218@gmail.com |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| National Cheng-Kung University Hospital | Recruiting | Tainan | 704 | Taiwan |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 38963694 | Derived | Wong CE, Chen PW, Hsu HJ, Cheng SY, Fan CC, Chen YC, Chiu YP, Lee JS, Liang SF. Collaborative Human-Computer Vision Operative Video Analysis Algorithm for Analyzing Surgical Fluency and Surgical Interruptions in Endonasal Endoscopic Pituitary Surgery: Cohort Study. J Med Internet Res. 2024 Jul 4;26:e56127. doi: 10.2196/56127. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D010911 | Pituitary Neoplasms |
| ID | Term |
|---|---|
| D004701 | Endocrine Gland Neoplasms |
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D007029 | Hypothalamic Neoplasms |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| D015173 |
| Supratentorial Neoplasms |
| D001932 | Brain Neoplasms |
| D016543 | Central Nervous System Neoplasms |
| D009423 | Nervous System Neoplasms |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
| D007027 | Hypothalamic Diseases |
| D010900 | Pituitary Diseases |
| D004700 | Endocrine System Diseases |